JONATHAN BRADD: Open Payments
NPI 1760034607 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 52 payments from 21 companies in 2025. Trend: 2023 $1,237 · 2024 $1,281 · 2025 $1,299
Food & beverage: $1,171Education: $128
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 6 | $150 |
| Sumitomo Pharma America, Inc. | 7 | $145 |
| Janssen Biotech, Inc. | 2 | $135 |
| PFIZER INC. | 7 | $114 |
| SEAGEN INC. | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| UROGEN PHARMA, INC. | 2 | $63 |
| Astellas Pharma US Inc | 3 | $62 |
| Boston Scientific Corporation | 2 | $55 |
Products named: XTANDI, PROVENGE, ORGOVYX, ERLEADA, PLUVICTO, Rezum Generator, ONGLYZA, JELMYTO.
Industry payments across MI — which companies pay providers there.
